1:00 p.m.Session Overview

 William Potter
 Cochair Emeritus,
 Neuroscience Steering Committee,
 FNIH Biomarkers Consortium
 Former Vice President, Translational Neuroscience,
 Merck & Co., Inc.

 William Thies
 Vice President, Medical & Scientific Relations
 National Alzheimer’s Association
1:10 p.m.Key Elements of ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward? The National Institutes of Health Perspective

 Neil Buckholtz
 Chief, Dementias of Aging Branch
 Division of Neuroscience
 National Institute on Aging
1:20 p.m.Key Elements of Japanese ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward?

 Ikuhisa Sawada
 Project Coordinator,
 Biotechnology and Medical Technology Development
 Department New Energy and Industrial Technology
 Development Organization
1:30 p.m.Key Elements of European ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward?

 Giovanni B. Frisoni
 Vice Scientific Director, IRCCS Centro San Giovanni di Dio FBF
 The National Centre for Alzheimer’s and Mental Diseases
1:40 p.m.Key Elements of Australian ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward?

 Christopher Rowe
 Director,
 Department of Nuclear Medicine and Centre for PET
 Professorial Fellow,
 University of Melbourne–Austin Health
1:50 p.m.Key Elements of ADNI and Moving Forward: What Lessons Can Be Learned For Moving Forward? An Industry Perspective

 Howard Feldman
 Vice President and Therapeutic Area Head,
 Global Clinical Research
 Neuroscience
 Bristol-Myers Squibb
2:00 p.m.Panel Discussion: Moving Forward—Identifying Opportunities and Future Synergies for ADNI 2

 Steven Paul, Panel Chair
 Executive Vice President, Science (Former)
 Eli Lilly

 Giovanni B. Frisoni
 Vice Scientific Director, IRCCS Centro San Giovanni di Dio FBF
 The National Centre for Alzheimer’s and Mental Diseases

 Howard Feldman
 Vice President and Therapeutic Area Head,
 Global Clinical Research
 Neuroscience
 Bristol-Myers Squibb

 Neil Buckholtz
 Chief, Dementias of Aging Branch
 Division of Neuroscience
 National Institute on Aging

 William Potter
 Cochair Emeritus,
 Neuroscience Steering Committee, FNIH Biomarkers Consortium
 Former Vice President, Translational Neuroscience,
 Merck & Co., Inc.

 Christopher Rowe
 Director,
 Department of Nuclear Medicine and Centre for PET
 Professorial Fellow,
 University of Melbourne–Austin Health

 Ikuhisa Sawada
 Project Coordinator,
 Biotechnology and Medical Technology Development
 Department New Energy and Industrial Technology
 Development Organization

 William Thies
 Vice President, Medical & Scientific Relations
 National Alzheimer’s Association
2:40 p.m.Discussion with Attendees

 Steven Paul, Panel Chair
 Executive Vice President, Science (Former)
 Eli Lilly
3:00 p.m.Adjourn

From: Appendix B, Workshop Agenda

Cover of Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative
Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative: Workshop Summary.
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.
Washington (DC): National Academies Press (US); 2011.
Copyright © 2011, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.